HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells.

Abstract
Human lung adenocarcinoma A549 cells stably transfected with TPalpha (A549-TPalpha) were used to study agonist I-BOP-induced expression of cyclooxygenase-2 (COX-2) and the related mechanisms of induced expression. I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells. The signaling pathways of I-BOP-induced COX-2 expression were elucidated by using various inhibitors of the signaling molecules. The effects of these inhibitors were assessed at protein level, enzyme activity and promoter activity of COX-2. Within MAPK family, both ERK and p38 MAPK but not JNK/SAPK pathways were involved in the induction. Other pathways such as JAK/Stat3 pathway and beta-catenin/TCF/LEF pathway also participated in the induction. The activation of key signaling molecules, ERK, p38 MAPK, CREB and NF-kappaB, involved in the COX-2 transcription was further studied at the phosphorylation step. Activation of ERK and p38 MAPK appeared to be mediated primarily by transactivation of EGFR, whereas activation of CREB and NF-kappaB was mediated by PKA, PKC and ERK. The role of CREB and NF-kappaB in I-BOP-induced COX-2 expression was further explored at the promoter level. Studies on promoter fragments and mutation of responsive motifs indicated that CRE and NF-kappaB sites are critical for the COX-2 induction. Distal NF-kappaB site is essential for the basal induction of the COX-2 transcription, whereas CRE and proximal NF-kappaB sites are important for the induced transcription. These results indicate that I-BOP-induced COX-2 expression through multiple signaling pathways.
AuthorsJingyan Wei, Weili Yan, Xiuling Li, Wen-Chang Chang, Hsin-Hsiung Tai
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 74 Issue 5 Pg. 787-800 (Sep 01 2007) ISSN: 1873-2968 [Electronic] England
PMID17632087 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • Fatty Acids, Unsaturated
  • Protein Isoforms
  • Receptors, Thromboxane
  • Receptors, Thromboxane A2, Prostaglandin H2
  • 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
  • Cyclooxygenase 2
Topics
  • Adenocarcinoma (enzymology, genetics, metabolism)
  • Bridged Bicyclo Compounds, Heterocyclic (pharmacology)
  • Cell Line, Tumor
  • Cyclooxygenase 2 (biosynthesis, genetics)
  • Enzyme Induction (drug effects)
  • Fatty Acids, Unsaturated (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Lung Neoplasms (enzymology, genetics, metabolism)
  • Protein Isoforms
  • Receptors, Thromboxane (agonists, metabolism)
  • Receptors, Thromboxane A2, Prostaglandin H2 (metabolism)
  • Signal Transduction (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: